Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4881)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 6, 2022 (publication date) through Apr 15, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lan CC, Hsieh PC, Huang CY, Yang MC, Su WL, Wu CW, Wu YK. Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis. World J Clin Cases 2022; 10(19): 6360-6369 [PMID: 35979322 DOI: 10.12998/wjcc.v10.i19.6360] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/6360.htm |
| Number | Citing Articles |
| 1 |
Ji Eun Park, Jaemin Jo, Sang Hoon Han, Chi Wha Han, Hwa Young Lee, Bo Gun Jang, Dong Hui Lee, Jieun Yang. Case report of short term EGFR TKI induced tubulointerstitial nephritis and IgA nephropathy in a patient with advanced non small cell lung cancer. Journal of Cancer Research and Therapeutics 2025; 21(1): 292 doi: 10.4103/jcrt.jcrt_430_24
|
| 2 |
Mostafa A. Ismail, Moustafa S. Abusaif, Mohamed S. A. El-Gaby, Yousry A. Ammar, Ahmed Ragab. A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety. RSC Advances 2023; 13(18): 12589 doi: 10.1039/D3RA01635H
|
| 3 |
Yidong Feng, Yiting Lv, Xiaoqi Zhang, Kodithuwakku Nandani Darshika, Hanmin Huang, Hanlin Feng, Zhongfeng Shi. NEP010, a novel compound with minor structural modification from afatinib, exhibited significantly improved antitumor activity. European Journal of Pharmacology 2023; 946: 175620 doi: 10.1016/j.ejphar.2023.175620
|
| 4 |
Ya-Tao Wang, Peng-Cheng Yang, Jing-Yi Zhang, Jin-Feng Sun. Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy. Molecules 2024; 29(7): 1448 doi: 10.3390/molecules29071448
|